106 related articles for article (PubMed ID: 59568)
1. [Therapy of dysmenorrhea].
Cazzola D
Ann Ostet Ginecol Med Perinat; 1975; 96(3):189-201. PubMed ID: 59568
[No Abstract] [Full Text] [Related]
2. [Intrahepatic cholestasis following ovosiston].
Kraatz G; Linke A
Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1194-6. PubMed ID: 4135044
[No Abstract] [Full Text] [Related]
3. Primary dysmenorrhea: combination vs sequential therapy.
Buttram VC; Kaufman RH
Tex Med; 1969 Aug; 65(8):52-5. PubMed ID: 4185963
[No Abstract] [Full Text] [Related]
4. Significance of dysmenorrhea in infertility. Report of a preliminary study of therapy with a sequential estrogen-progestagen regimen.
Roland M; Clyman M; Decker A; Ober WB
Pac Med Surg; 1966; 74(3):135-8. PubMed ID: 4160710
[No Abstract] [Full Text] [Related]
5. [Gestranol in treatment of excessive postpartum breast intumescence].
Ostrzeński A
Pol Tyg Lek; 1974 Mar; 29(12):489-90. PubMed ID: 4132234
[No Abstract] [Full Text] [Related]
6. [Treatment of seborrheic conditions of the female scalp using modern combined peroral estrogen-gestagen preparations].
Spirov G; Berova N; Vasilev D
Vestn Dermatol Venerol; 1973 Jul; 47(7):30-3. PubMed ID: 4127925
[No Abstract] [Full Text] [Related]
7. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
Bernard I
Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
[No Abstract] [Full Text] [Related]
8. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.
Matthews AE; Clarke JE
J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1117-22. PubMed ID: 4177921
[No Abstract] [Full Text] [Related]
9. Modified sequential oral contraception employing mestranol with chlormadinone.
Tyler ET; Matsner EM; Gotlib M
Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
[No Abstract] [Full Text] [Related]
10. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
Müller R; Kempf HJ; Eckert L
Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
[No Abstract] [Full Text] [Related]
11. [Treatment of erythema nodosum with an estrogen-gestagen hormonal preparation].
Spirov G; Vetsova N
Vestn Dermatol Venerol; 1975 Feb; (2):57-8. PubMed ID: 50675
[No Abstract] [Full Text] [Related]
12. Effect of sequential mestranol-chlormadinone on sebum production.
Pochi PE; Strauss JS
Arch Dermatol; 1967 Jan; 95(1):47-9. PubMed ID: 4163188
[No Abstract] [Full Text] [Related]
13. [Clinical results of Lunarol, synthetic corpus luteum and follicle hormones preparation with special reference to corpus luteum insufficiency and amenorrhea].
Iizuka R; Koi H; Saga M; Shibuya T; Hongo K
Sanfujinka No Jissai; 1970; 19(3):322-30. PubMed ID: 4192774
[No Abstract] [Full Text] [Related]
14. [Coronary infarction associated with ovulation inhibitors].
Dejaco RM; Hartl O; Pürgyi P
Wien Med Wochenschr; 1972 Nov; 122(43):630-2. PubMed ID: 4120546
[No Abstract] [Full Text] [Related]
15. [Effect of mestranol and chlormadinone acetate on HGH secretion in Turner's syndrome].
Rudolf K; Kunkel S; Woltanski KP
Zentralbl Gynakol; 1985; 107(23):1454-9. PubMed ID: 2420102
[TBL] [Abstract][Full Text] [Related]
16. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
Krause W; Böhm W; Müller W
Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
[No Abstract] [Full Text] [Related]
17. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
Ebeling K; Kühndel K; Rothe K; Canzler E
Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1275-8. PubMed ID: 4111418
[No Abstract] [Full Text] [Related]
18. [Effect of mestranol and chlormadinone acetate on basal and TRH-stimulated PRL secretion in Turner's syndrome].
Rudolf K; Kunkel S; Pelz L
Zentralbl Gynakol; 1985; 107(23):1446-53. PubMed ID: 2420101
[TBL] [Abstract][Full Text] [Related]
19. [Personal experience in the management of the post-menopausal patient using sequential 11 plus 10 therapy (mestranol 30 mcg. and chlormadinone 1 mlg. plus mestranol 80 mcg)].
González Gutiérrez JT
Ginecol Obstet Mex; 1969 May; 24(151):531-7. PubMed ID: 4186794
[No Abstract] [Full Text] [Related]
20. [Experiences with a gestagen-estrogen preparation (AK 103=Aconcen)].
Kalchauer B
Ther Ggw; 1966 Jul; 105(7):938-9. PubMed ID: 4162578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
